As previously reported, Goldman Sachs analyst David Tamberrino upgraded Lear (LEA) to Buy from Neutral, telling investors that he sees the potential for the company to win new business from Adient (ADNT), which is facing its own operational challenges. Following a heavy launch period, Tamberrino projects a 6% revenue CAGR through 2022 for Lear and sees upside potential to its long-term margin guidance. Additionally, he views the stock's current valuation as "undemanding," particularly in light of its free cash flow yield. However, Tamberrino lowered his price target on Lear shares to $195 from $198.